Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 14.2B | 12.7B | 13.9B | 12.5B |
| Cost of revenue | 10.6B | 9.6B | 10.6B | 9.4B |
| Gross profit | 3.6B | 3.1B | 3.2B | 3.0B |
| Operating expense | ||||
| Research & development | 84.8M | 37.4M | 49.0M | 38.7M |
| Selling general and admin | 1.9B | 1.6B | 1.7B | 1.5B |
| Other operating expenses | — | — | — | — |
| Operating income | 1.6B | 1.4B | 1.5B | 1.5B |
| Non operating interest income | ||||
| Income | 10.2M | 13.4M | 9.4M | 12.3M |
| Expense | 218.1M | 148.5M | 172.5M | 184.1M |
| Other income expense | 465.5M | 436.2M | 108.2M | 349.7M |
| Pretax income | 1.8B | 1.7B | 1.5B | 1.7B |
| Tax provision | 358.5M | 302.7M | 130.3M | 389.8M |
| Net income | 1.5B | 1.4B | 1.3B | 1.3B |
| Basic EPS | 0.9 | 0.8 | 0.8 | 0.8 |
| Diluted EPS | 0.9 | 0.8 | 0.8 | 0.8 |
| Basic average shares | 1.7B | 1.7B | 1.7B | 1.7B |
| Diluted average shares | 1.7B | 1.7B | 1.7B | 1.7B |
| EBITDA | 2.5B | 2.2B | 2.1B | 2.3B |
| Net income from continuing op. | 1.5B | 1.4B | 1.3B | 1.3B |
| Minority interests | -1.4M | -1.2M | -1.1M | -2.9M |
| Preferred stock dividends | — | — | — | — |